Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care

Introduction The direction of the causal link between solid cancers and elevated plasma vitamin B 12 (B 12 ) remains uncertain. Material and methods We retrospectively included patients having two B 12 measurements with a B 12 initially ≥ 1000 ng/l and a solid cancer diagnosed between the measur...

Full description

Bibliographic Details
Main Authors: Valentin Lacombe, Anne Patsouris, Estelle Delattre, Carole Lacout, Geoffrey Urbanski
Format: Article
Language:English
Published: Termedia Publishing House 2021-09-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/Evolution-of-plasma-vitamin-B-12-in-patients-with-solid-cancers-during-curative-versus,140974,0,2.html
_version_ 1811252793264046080
author Valentin Lacombe
Anne Patsouris
Estelle Delattre
Carole Lacout
Geoffrey Urbanski
author_facet Valentin Lacombe
Anne Patsouris
Estelle Delattre
Carole Lacout
Geoffrey Urbanski
author_sort Valentin Lacombe
collection DOAJ
description Introduction The direction of the causal link between solid cancers and elevated plasma vitamin B 12 (B 12 ) remains uncertain. Material and methods We retrospectively included patients having two B 12 measurements with a B 12 initially ≥ 1000 ng/l and a solid cancer diagnosed between the measurements. Patients were included in the Curative or Supportive group according to their treatments. Results B 12 changes over time differed among groups ( p = 0.001): +157.4 ng/L/month in the Supportive care group versus -171.6 ng/L/month in the Curative care group. Conclusions The decrease of plasma B 12 in cases of curative care could suggest that this B 12 elevation is secondary to solid cancers.
first_indexed 2024-04-12T16:40:00Z
format Article
id doaj.art-feeef4ac39b0469dac64771f7dfce7f2
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-04-12T16:40:00Z
publishDate 2021-09-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-feeef4ac39b0469dac64771f7dfce7f22022-12-22T03:24:50ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512021-09-011761811181510.5114/aoms/140974140974Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive careValentin Lacombe0Anne Patsouris1Estelle Delattre2Carole Lacout3Geoffrey Urbanski4https://orcid.org/0000-0001-5719-8423Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, FranceMedical Oncology, Ouest Cancerology Institute, Angers, FranceDepartment of Internal Medicine and Clinical Immunology, University Hospital, Angers, FranceDepartment of Internal Medicine and Clinical Immunology, University Hospital, Angers, FranceDepartment of Internal Medicine and Clinical Immunology, University Hospital, Angers, FranceIntroduction The direction of the causal link between solid cancers and elevated plasma vitamin B 12 (B 12 ) remains uncertain. Material and methods We retrospectively included patients having two B 12 measurements with a B 12 initially ≥ 1000 ng/l and a solid cancer diagnosed between the measurements. Patients were included in the Curative or Supportive group according to their treatments. Results B 12 changes over time differed among groups ( p = 0.001): +157.4 ng/L/month in the Supportive care group versus -171.6 ng/L/month in the Curative care group. Conclusions The decrease of plasma B 12 in cases of curative care could suggest that this B 12 elevation is secondary to solid cancers.https://www.archivesofmedicalscience.com/Evolution-of-plasma-vitamin-B-12-in-patients-with-solid-cancers-during-curative-versus,140974,0,2.htmlvitamin b 12neoplasmsneoplasm metastasisantineoplastic agents
spellingShingle Valentin Lacombe
Anne Patsouris
Estelle Delattre
Carole Lacout
Geoffrey Urbanski
Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care
Archives of Medical Science
vitamin b 12
neoplasms
neoplasm metastasis
antineoplastic agents
title Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care
title_full Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care
title_fullStr Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care
title_full_unstemmed Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care
title_short Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care
title_sort evolution of plasma vitamin b 12 in patients with solid cancers during curative versus supportive care
topic vitamin b 12
neoplasms
neoplasm metastasis
antineoplastic agents
url https://www.archivesofmedicalscience.com/Evolution-of-plasma-vitamin-B-12-in-patients-with-solid-cancers-during-curative-versus,140974,0,2.html
work_keys_str_mv AT valentinlacombe evolutionofplasmavitaminb12inpatientswithsolidcancersduringcurativeversussupportivecare
AT annepatsouris evolutionofplasmavitaminb12inpatientswithsolidcancersduringcurativeversussupportivecare
AT estelledelattre evolutionofplasmavitaminb12inpatientswithsolidcancersduringcurativeversussupportivecare
AT carolelacout evolutionofplasmavitaminb12inpatientswithsolidcancersduringcurativeversussupportivecare
AT geoffreyurbanski evolutionofplasmavitaminb12inpatientswithsolidcancersduringcurativeversussupportivecare